vimarsana.com
Home
Live Updates
AGTC to Showcase Interim Findings from Ongoing XLRP and : vi
AGTC to Showcase Interim Findings from Ongoing XLRP and : vi
AGTC to Showcase Interim Findings from Ongoing XLRP and
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a clinical...
Related Keywords
Colorado ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Oregon ,
Denver ,
Jonathan Lieber ,
Rachel Huckfeldt ,
Paul Yang ,
Kerry Sinclair ,
Susan Schneider ,
Alessandro Iannaccone ,
Genetic Technologies Corporation ,
Professor Of Ophthalmology At Harvard Medical School ,
Spectrum Science Communications ,
Otonomy Inc ,
Nasdaq ,
Casey Eye Institute ,
Oregon Health Science University In Portland ,
Association For Research ,
Chief Medical Officer ,
Visual Photosensitivity ,
Two Phase ,
Subretinal Gene Therapy ,
Assistant Professor ,
Harvard Medical School ,
Four Seasons Ballroom ,
Safety Results ,
Dose Escalation Clinical Trials ,
Retinal Degenerations ,
Ophthalmic Genetic Diseases ,
Duke University School ,
Month Analysis ,
Subretinal Gene Therapy Drug ,
X Linked Retinitis Pigmentosa ,
Oregon Health ,
Science University ,
Bionic Sight ,
Looking Statements ,
Nasdaq Agtc ,
Applied Genetic Technologies Corporation ,